Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rees

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Cellular Signalling|January 16, 1998
Molecular cloning and expression of a human phosphodiesterase 4CR J Owens, S Lumb, K Rees-Milton, et al.
Proceedings. Biological Sciences|July 16, 2024
Facial expressivity in dominant macaques is linked to group cohesionJ Whitehouse, P R Clark, R L Robinson, et al.
Epidemiology and Infection|December 7, 2017
The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysisK Rees, N Muditambi, M Maswanganyi, et al.
British Journal of Haematology|November 1, 1991
Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemiaC F Hoyle, R G Gray, K Wheatley, et al.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
Health Technology Assessment (Winchester, England)|October 6, 2004
Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groupsA D Beswick, K Rees, I Griebsch, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Molecules (Basel, Switzerland)|February 13, 2025
Phytochemical Profile and Biological Activities of the Endemic <i>Thymbra nabateorum</i> Occurring in AlUla County, NW Saudi ArabiaMohamed Djamel Miara, Sami Youssef, Yassine Fendane, et al.
Heart (British Cardiac Society)|February 16, 2005
Cardiac rehabilitation in the UK: uptake among under-represented groupsK Rees, J Victory, A D Beswick, et al.
Journal of Paediatrics and Child Health|September 5, 2001
Risk factors for small-for-gestational-age babies: The Auckland Birthweight Collaborative StudyJ M Thompson, P M Clark, E Robinson, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Cellular Signalling|January 16, 1998
Molecular cloning and expression of a human phosphodiesterase 4CR J Owens, S Lumb, K Rees-Milton, et al.
Proceedings. Biological Sciences|July 16, 2024
Facial expressivity in dominant macaques is linked to group cohesionJ Whitehouse, P R Clark, R L Robinson, et al.
Epidemiology and Infection|December 7, 2017
The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysisK Rees, N Muditambi, M Maswanganyi, et al.
British Journal of Haematology|November 1, 1991
Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemiaC F Hoyle, R G Gray, K Wheatley, et al.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
Health Technology Assessment (Winchester, England)|October 6, 2004
Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groupsA D Beswick, K Rees, I Griebsch, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Molecules (Basel, Switzerland)|February 13, 2025
Phytochemical Profile and Biological Activities of the Endemic <i>Thymbra nabateorum</i> Occurring in AlUla County, NW Saudi ArabiaMohamed Djamel Miara, Sami Youssef, Yassine Fendane, et al.
Heart (British Cardiac Society)|February 16, 2005
Cardiac rehabilitation in the UK: uptake among under-represented groupsK Rees, J Victory, A D Beswick, et al.
Journal of Paediatrics and Child Health|September 5, 2001
Risk factors for small-for-gestational-age babies: The Auckland Birthweight Collaborative StudyJ M Thompson, P M Clark, E Robinson, et al.
Pageof 12